Compare ETFs: LON:BTEC vs. IBB
LON:BTEC
IBB
Comparison
Average Return
In the past year, LON:BTEC returned a total of 29.39%, which is significantly higher than IBB's 22.61% return. Over the past 5 years, LON:BTEC has had annualized average returns of 4.32%, compared to 1.74% for IBB. These numbers are adjusted for stock splits and include dividends.
Top 25 Holdings
| LON:BTEC - iShares NASDAQ US Biotechnology UCITS ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | GILD | Gilead Sciences, Inc. | 7.81% |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 7.71% |
| 3 | AMGN | Amgen Inc. | 7.67% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 6.37% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.57% |
| 6 | INSM | Insmed Incorporated | 2.61% |
| 7 | BIIB | Biogen Inc. | 2.27% |
| 8 | UTHR | United Therapeutics Corporation | 1.94% |
| 9 | MRNA | Moderna, Inc. | 1.73% |
| 10 | RPRX | Royalty Pharma plc | 1.65% |
| 11 | ARGX | argenx SE | 1.62% |
| 12 | ROIV | Roivant Sciences Ltd. | 1.61% |
| 13 | ILMN | Illumina, Inc. | 1.58% |
| 14 | RVMD | Revolution Medicines, Inc. | 1.53% |
| 15 | INCY | Incyte Corporation | 1.50% |
| 16 | VTRS | Viatris Inc. | 1.27% |
| 17 | BBIO | BridgeBio Pharma, Inc. | 1.14% |
| 18 | SMMT | Summit Therapeutics Inc. | 1.14% |
| 19 | ASND | Ascendis Pharma A/S | 1.11% |
| 20 | MEDP | Medpace Holdings, Inc. | 1.08% |
| 21 | NBIX | Neurocrine Biosciences, Inc. | 1.08% |
| 22 | IONS | Ionis Pharmaceuticals, Inc. | 0.98% |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 0.96% |
| 24 | GH | Guardant Health, Inc. | 0.93% |
| 25 | SNY | Sanofi | 0.92% |
| View LON:BTEC holdings | |||
| IBB - iShares Biotechnology ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | GILD | Gilead Sciences, Inc. | 7.86% |
| 2 | AMGN | Amgen Inc. | 7.83% |
| 3 | VRTX | Vertex Pharmaceuticals Incorporated | 7.60% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 7.25% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 4.03% |
| 6 | ARGX | argenx SE | 3.06% |
| 7 | INSM | Insmed Incorporated | 2.99% |
| 8 | BIIB | Biogen Inc. | 2.60% |
| 9 | NTRA | Natera, Inc. | 2.32% |
| 10 | UTHR | United Therapeutics Corporation | 2.14% |
| 11 | ONC | BeOne Medicines AG | 1.94% |
| 12 | MRNA | Moderna, Inc. | 1.73% |
| 13 | INCY | Incyte Corporation | 1.72% |
| 14 | ILMN | Illumina, Inc. | 1.69% |
| 15 | RVMD | Revolution Medicines, Inc. | 1.54% |
| 16 | ROIV | Roivant Sciences Ltd. | 1.25% |
| 17 | NBIX | Neurocrine Biosciences, Inc. | 1.21% |
| 18 | GMAB | Genmab A/S | 1.19% |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 1.13% |
| 20 | BBIO | BridgeBio Pharma, Inc. | 1.12% |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.03% |
| 22 | EXEL | Exelixis, Inc. | 1.01% |
| 23 | MEDP | Medpace Holdings, Inc. | 0.99% |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 0.99% |
| 25 | ASND | Ascendis Pharma A/S | 0.96% |
| View IBB holdings | |||